Global Transmucosal Drug Delivery Market Size, Status and Forecast 2021-2027

Global Transmucosal Drug Delivery Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Passive Transdermal Drug Delivery
1.2.3 Active Transdermal Drug Delivery
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Market Perspective (2016-2027)
2.2 Transmucosal Drug Delivery Growth Trends by Regions
2.2.1 Transmucosal Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transmucosal Drug Delivery Historic Market Share by Regions (2016-2021)
2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Regions (2022-2027)
2.3 Transmucosal Drug Delivery Industry Dynamic
2.3.1 Transmucosal Drug Delivery Market Trends
2.3.2 Transmucosal Drug Delivery Market Drivers
2.3.3 Transmucosal Drug Delivery Market Challenges
2.3.4 Transmucosal Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Players by Revenue
3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2016-2021)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2016-2021)
3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue
3.4 Global Transmucosal Drug Delivery Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2020
3.5 Transmucosal Drug Delivery Key Players Head office and Area Served
3.6 Key Players Transmucosal Drug Delivery Product Solution and Service
3.7 Date of Enter into Transmucosal Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2016-2021)
4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2022-2027)
5 Transmucosal Drug Delivery Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2016-2021)
5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Transmucosal Drug Delivery Market Size (2016-2027)
6.2 North America Transmucosal Drug Delivery Market Size by Type
6.2.1 North America Transmucosal Drug Delivery Market Size by Type (2016-2021)
6.2.2 North America Transmucosal Drug Delivery Market Size by Type (2022-2027)
6.2.3 North America Transmucosal Drug Delivery Market Size by Type (2016-2027)
6.3 North America Transmucosal Drug Delivery Market Size by Application
6.3.1 North America Transmucosal Drug Delivery Market Size by Application (2016-2021)
6.3.2 North America Transmucosal Drug Delivery Market Size by Application (2022-2027)
6.3.3 North America Transmucosal Drug Delivery Market Size by Application (2016-2027)
6.4 North America Transmucosal Drug Delivery Market Size by Country
6.4.1 North America Transmucosal Drug Delivery Market Size by Country (2016-2021)
6.4.2 North America Transmucosal Drug Delivery Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Market Size (2016-2027)
7.2 Europe Transmucosal Drug Delivery Market Size by Type
7.2.1 Europe Transmucosal Drug Delivery Market Size by Type (2016-2021)
7.2.2 Europe Transmucosal Drug Delivery Market Size by Type (2022-2027)
7.2.3 Europe Transmucosal Drug Delivery Market Size by Type (2016-2027)
7.3 Europe Transmucosal Drug Delivery Market Size by Application
7.3.1 Europe Transmucosal Drug Delivery Market Size by Application (2016-2021)
7.3.2 Europe Transmucosal Drug Delivery Market Size by Application (2022-2027)
7.3.3 Europe Transmucosal Drug Delivery Market Size by Application (2016-2027)
7.4 Europe Transmucosal Drug Delivery Market Size by Country
7.4.1 Europe Transmucosal Drug Delivery Market Size by Country (2016-2021)
7.4.2 Europe Transmucosal Drug Delivery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Transmucosal Drug Delivery Market Size (2016-2027)
8.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2027)
8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2027)
8.4 Asia-Pacific Transmucosal Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transmucosal Drug Delivery Market Size (2016-2027)
9.2 Latin America Transmucosal Drug Delivery Market Size by Type
9.2.1 Latin America Transmucosal Drug Delivery Market Size by Type (2016-2021)
9.2.2 Latin America Transmucosal Drug Delivery Market Size by Type (2022-2027)
9.2.3 Latin America Transmucosal Drug Delivery Market Size by Type (2016-2027)
9.3 Latin America Transmucosal Drug Delivery Market Size by Application
9.3.1 Latin America Transmucosal Drug Delivery Market Size by Application (2016-2021)
9.3.2 Latin America Transmucosal Drug Delivery Market Size by Application (2022-2027)
9.3.3 Latin America Transmucosal Drug Delivery Market Size by Application (2016-2027)
9.4 Latin America Transmucosal Drug Delivery Market Size by Country
9.4.1 Latin America Transmucosal Drug Delivery Market Size by Country (2016-2021)
9.4.2 Latin America Transmucosal Drug Delivery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transmucosal Drug Delivery Market Size (2016-2027)
10.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2027)
10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2027)
10.4 Middle East & Africa Transmucosal Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Details
11.1.2 3M Pharmaceuticals Business Overview
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
11.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.1.5 3M Pharmaceuticals Recent Development
11.2 Acrux Limited
11.2.1 Acrux Limited Company Details
11.2.2 Acrux Limited Business Overview
11.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
11.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.2.5 Acrux Limited Recent Development
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Details
11.3.2 ALZA Corporation Business Overview
11.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
11.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.3.5 ALZA Corporation Recent Development
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Details
11.4.2 Antares Pharma, Inc. Business Overview
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
11.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.4.5 Antares Pharma, Inc. Recent Development
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Details
11.5.2 Apricus BioSciences, Inc Business Overview
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
11.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.5.5 Apricus BioSciences, Inc Recent Development
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Details
11.6.2 Aveva Drug Delivery Systems Business Overview
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
11.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.6.5 Aveva Drug Delivery Systems Recent Development
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Details
11.7.2 Corium International, Inc Business Overview
11.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
11.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.7.5 Corium International, Inc Recent Development
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Details
11.8.2 DURECT Corporation Business Overview
11.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
11.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.8.5 DURECT Corporation Recent Development
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Details
11.9.2 Generex Biotechnology Corporation Business Overview
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
11.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.9.5 Generex Biotechnology Corporation Recent Development
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Details
11.10.2 Inovio Pharmaceuticals, Inc. Business Overview
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.10.5 Inovio Pharmaceuticals, Inc. Recent Development
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Details
11.12.2 MedPharm LTD Business Overview
11.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
11.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.12.5 MedPharm LTD Recent Development
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Details
11.13.2 Mylan, Inc. Business Overview
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
11.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.13.5 Mylan, Inc. Recent Development
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Details
11.14.2 Nemaura Pharma Ltd Business Overview
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
11.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.14.5 Nemaura Pharma Ltd Recent Development
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Details
11.15.2 Nitto Denko Corporation Business Overview
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
11.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.15.5 Nitto Denko Corporation Recent Development
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Details
11.16.2 Noven Pharmaceuticals, Inc. Business Overview
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.16.5 Noven Pharmaceuticals, Inc. Recent Development
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Details
11.17.2 Pantec Biosolutions AG Business Overview
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
11.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.17.5 Pantec Biosolutions AG Recent Development
11.18 Tapemark
11.18.1 Tapemark Company Details
11.18.2 Tapemark Business Overview
11.18.3 Tapemark Transmucosal Drug Delivery Introduction
11.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.18.5 Tapemark Recent Development
11.18 tesa Labtec GmbH
.1 tesa Labtec GmbH Company Details
.2 tesa Labtec GmbH Business Overview
.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2016-2021)
.5 tesa Labtec GmbH Recent Development
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
11.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Details
11.21.2 Zosano Pharma Business Overview
11.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
11.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.21.5 Zosano Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Passive Transdermal Drug Delivery
Table 3. Key Players of Active Transdermal Drug Delivery
Table 4. Global Transmucosal Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Transmucosal Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Transmucosal Drug Delivery Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Transmucosal Drug Delivery Market Share by Regions (2016-2021)
Table 8. Global Transmucosal Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Transmucosal Drug Delivery Market Share by Regions (2022-2027)
Table 10. Transmucosal Drug Delivery Market Trends
Table 11. Transmucosal Drug Delivery Market Drivers
Table 12. Transmucosal Drug Delivery Market Challenges
Table 13. Transmucosal Drug Delivery Market Restraints
Table 14. Global Transmucosal Drug Delivery Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Transmucosal Drug Delivery Market Share by Players (2016-2021)
Table 16. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2020)
Table 17. Ranking of Global Top Transmucosal Drug Delivery Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Transmucosal Drug Delivery Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Transmucosal Drug Delivery Product Solution and Service
Table 21. Date of Enter into Transmucosal Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Transmucosal Drug Delivery Revenue Market Share by Type (2016-2021)
Table 25. Global Transmucosal Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Transmucosal Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Transmucosal Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Transmucosal Drug Delivery Revenue Market Share by Application (2016-2021)
Table 29. Global Transmucosal Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Transmucosal Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 61. 3M Pharmaceuticals Company Details
Table 62. 3M Pharmaceuticals Business Overview
Table 63. 3M Pharmaceuticals Transmucosal Drug Delivery Product
Table 64. 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 65. 3M Pharmaceuticals Recent Development
Table 66. Acrux Limited Company Details
Table 67. Acrux Limited Business Overview
Table 68. Acrux Limited Transmucosal Drug Delivery Product
Table 69. Acrux Limited Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 70. Acrux Limited Recent Development
Table 71. ALZA Corporation Company Details
Table 72. ALZA Corporation Business Overview
Table 73. ALZA Corporation Transmucosal Drug Delivery Product
Table 74. ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 75. ALZA Corporation Recent Development
Table 76. Antares Pharma, Inc. Company Details
Table 77. Antares Pharma, Inc. Business Overview
Table 78. Antares Pharma, Inc. Transmucosal Drug Delivery Product
Table 79. Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 80. Antares Pharma, Inc. Recent Development
Table 81. Apricus BioSciences, Inc Company Details
Table 82. Apricus BioSciences, Inc Business Overview
Table 83. Apricus BioSciences, Inc Transmucosal Drug Delivery Product
Table 84. Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 85. Apricus BioSciences, Inc Recent Development
Table 86. Aveva Drug Delivery Systems Company Details
Table 87. Aveva Drug Delivery Systems Business Overview
Table 88. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product
Table 89. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 90. Aveva Drug Delivery Systems Recent Development
Table 91. Corium International, Inc Company Details
Table 92. Corium International, Inc Business Overview
Table 93. Corium International, Inc Transmucosal Drug Delivery Product
Table 94. Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 95. Corium International, Inc Recent Development
Table 96. DURECT Corporation Company Details
Table 97. DURECT Corporation Business Overview
Table 98. DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 99. DURECT Corporation Recent Development
Table 100. Generex Biotechnology Corporation Company Details
Table 101. Generex Biotechnology Corporation Business Overview
Table 102. Generex Biotechnology Corporation Transmucosal Drug Delivery Product
Table 103. Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 104. Generex Biotechnology Corporation Recent Development
Table 105. Inovio Pharmaceuticals, Inc. Company Details
Table 106. Inovio Pharmaceuticals, Inc. Business Overview
Table 107. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
Table 108. Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 109. Inovio Pharmaceuticals, Inc. Recent Development
Table 110. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
Table 111. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
Table 112. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product
Table 113. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 114. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
Table 115. MedPharm LTD Company Details
Table 116. MedPharm LTD Business Overview
Table 117. MedPharm LTD Transmucosal Drug Delivery Product
Table 118. MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 119. MedPharm LTD Recent Development
Table 120. Mylan, Inc. Company Details
Table 121. Mylan, Inc. Business Overview
Table 122. Mylan, Inc. Transmucosal Drug Delivery Product
Table 123. Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 124. Mylan, Inc. Recent Development
Table 125. Nemaura Pharma Ltd Company Details
Table 126. Nemaura Pharma Ltd Business Overview
Table 127. Nemaura Pharma Ltd Transmucosal Drug Delivery Product
Table 128. Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 129. Nemaura Pharma Ltd Recent Development
Table 130. Nitto Denko Corporation Company Details
Table 131. Nitto Denko Corporation Business Overview
Table 132. Nitto Denko Corporation Transmucosal Drug Delivery Product
Table 133. Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 134. Nitto Denko Corporation Recent Development
Table 135. Noven Pharmaceuticals, Inc. Company Details
Table 136. Noven Pharmaceuticals, Inc. Business Overview
Table 137. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
Table 138. Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 139. Noven Pharmaceuticals, Inc. Recent Development
Table 140. Pantec Biosolutions AG Company Details
Table 141. Pantec Biosolutions AG Business Overview
Table 142. Pantec Biosolutions AG Transmucosal Drug Delivery Product
Table 143. Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 144. Pantec Biosolutions AG Recent Development
Table 145. Tapemark Company Details
Table 146. Tapemark Business Overview
Table 147. Tapemark Transmucosal Drug Delivery Product
Table 148. Tapemark Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 149. Tapemark Recent Development
Table 150. tesa Labtec GmbH Company Details
Table 151. tesa Labtec GmbH Business Overview
Table 152. tesa Labtec GmbH Transmucosal Drug Delivery Product
Table 153. tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 154. tesa Labtec GmbH Recent Development
Table 155. TEVA Pharmaceutical Industries Ltd. Company Details
Table 156. TEVA Pharmaceutical Industries Ltd. Business Overview
Table 157. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product
Table 158. TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 159. TEVA Pharmaceutical Industries Ltd. Recent Development
Table 160. Zosano Pharma Company Details
Table 161. Zosano Pharma Business Overview
Table 162. Zosano Pharma Transmucosal Drug Delivery Product
Table 163. Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 164. Zosano Pharma Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transmucosal Drug Delivery Market Share by Type: 2020 VS 2027
Figure 2. Passive Transdermal Drug Delivery Features
Figure 3. Active Transdermal Drug Delivery Features
Figure 4. Global Transmucosal Drug Delivery Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Transmucosal Drug Delivery Report Years Considered
Figure 9. Global Transmucosal Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Transmucosal Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Transmucosal Drug Delivery Market Share by Regions: 2020 VS 2027
Figure 12. Global Transmucosal Drug Delivery Market Share by Regions (2022-2027)
Figure 13. Global Transmucosal Drug Delivery Market Share by Players in 2020
Figure 14. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2020
Figure 16. Global Transmucosal Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 17. Global Transmucosal Drug Delivery Revenue Market Share by Type (2022-2027)
Figure 18. North America Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Transmucosal Drug Delivery Market Share by Type (2016-2027)
Figure 20. North America Transmucosal Drug Delivery Market Share by Application (2016-2027)
Figure 21. North America Transmucosal Drug Delivery Market Share by Country (2016-2027)
Figure 22. United States Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Transmucosal Drug Delivery Market Share by Type (2016-2027)
Figure 26. Europe Transmucosal Drug Delivery Market Share by Application (2016-2027)
Figure 27. Europe Transmucosal Drug Delivery Market Share by Country (2016-2027)
Figure 28. Germany Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Transmucosal Drug Delivery Market Size YoY Growth (2016-2027

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Gold Nanoparticles Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 121

Gold nanoparticles are particles with diameters in The 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photovoltaics, sensory probes, therapeutic agents, drug delivery in biological and medical applications, electronic conductors and catalysis. The optical and electronic properties of gold nanoparticles are tunable by changing The size, shape, surface chemi......

Global High Volume Subcutaneous Drug Delivery Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 109

Market Overview of Global High Volume Subcutaneous Drug Delivery market: According to our latest research, the global High Volume Subcutaneous Drug Delivery market looks promising in the next 5 years. As of 2022, the global High Volume Subcutaneous Drug Delivery market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a dee......

Global Gold Nanoparticles Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Gold Nanoparticles market size was valued at US$ 86 million in 2023. With growing demand in downstream market, the Gold Nanoparticles is forecast to a readjusted size of US$ 200.8 million by 2030 with a CAGR of 12.9% during review period. The research report highlights the growth potential of the global Gold Nanoparticles market. Gold Nanoparticles are expected to show stable growth in the future market. However, product diff......

Global Liposome Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 123

According to our LPI (LP Information) latest study, the global Liposome Drug Delivery market size was valued at US$ 3652.8 million in 2023. With growing demand in downstream market, the Liposome Drug Delivery is forecast to a readjusted size of US$ 8742.8 million by 2030 with a CAGR of 13.3% during review period. The research report highlights the growth potential of the global Liposome Drug Delivery market. Liposome Drug Delivery are expected to show stable growth in the future market. ......

Global Transdermal Drug Delivery System Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Transdermal Drug Delivery System market size was valued at US$ 14730 million in 2023. With growing demand in downstream market, the Transdermal Drug Delivery System is forecast to a readjusted size of US$ 36410 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Transdermal Drug Delivery System market. Transdermal Drug Delivery System are expected to sho......

Global Liposomes Drug Delivery Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117

According to our LPI (LP Information) latest study, the global Liposomes Drug Delivery market size was valued at US$ 3262.7 million in 2023. With growing demand in downstream market, the Liposomes Drug Delivery is forecast to a readjusted size of US$ 6510.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Liposomes Drug Delivery market. Liposomes Drug Delivery are expected to show stable growth in the future mark......

Global Gold Nanoparticles Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 129

According to our (Global Info Research) latest study, the global Gold Nanoparticles market size was valued at USD 91 million in 2023 and is forecast to a readjusted size of USD 198.5 million by 2030 with a CAGR of 11.9% during review period. Gold nanoparticles are particles with diameters in the 1-100nm range and have unique optical and physical properties. These unique optical-electronics properties have been researched and utilized in high technology applications such as organic photov......

Global Polymers Drug Delivery Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 160

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

Global Polymers Drug Delivery Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 135

Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drugs in the body. Polymeric drug delivery system has defined as a formulation or a device that enables the introduction of a therapeutic substance into the body. It improves its safety and efficacy by controlling the rate, time, and place of release of drug......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs